Alphadyne Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,600
Closed -$1.28M 1106
2026
Q1
$1.28M Buy
+2,600
New +$1.41M 0.02% 527
2025
Q4
Sell
-1,500
Closed -$728K 899
2025
Q3
$728K Sell
1,500
-200
-12% -$93.1K 0.06% 220
2025
Q2
$689K Buy
+1,700
New +$711K 0.13% 71
2023
Q4
Sell
-7,400
Closed -$3.75M 158
2023
Q3
$3.75M Buy
7,400
+4,300
+139% +$2.29M 0.28% 76
2023
Q2
$1.62M Buy
+3,100
New +$1.67M 0.2% 49

Other funds holding TMO

Alphadyne Asset Management's TMO Position: Q2 2026 in Review

Alphadyne Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 75% in Q2 2026, selling an estimated $970K and leaving 672 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Alphadyne Asset Management first reported a position in TMO in Q2 2023 and has held it in 4 quarters since. The position peaked at $2.23M in Q3 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Alphadyne Asset Management held 672 shares of Thermo Fisher Scientific worth $337K as of Q2 2026.
  • Alphadyne Asset Management sold 2,020 Thermo Fisher Scientific shares in Q2 2026, an estimated $970K.
  • Thermo Fisher Scientific made up ﹤0.01% of Alphadyne Asset Management's portfolio in Q2 2026, its #702 holding.
  • Alphadyne Asset Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 4 quarters since.
  • Alphadyne Asset Management's Thermo Fisher Scientific position peaked at $2.23M in Q3 2023.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.